. The PACT has eight subscales, each rated on a 5-point scale, and an initial and final rating independently based on the rater's overall impressions of the candidate's acceptability for transplant. This exploratory study assessed the clinical utility of the PACT scale for psychosocial screening in allogeneic BMT. Associations of the PACT subscales and the final rating with sixteen post transplant medical outcomes were examined using the Jonchkheere-Terpstra test, the Cochran-Armitage test or the Cox proportional hazards analysis. Significant relationships (Pp0.05) between PACT subscales and medical outcomes are as follows: better compliance with medications and medical advice associates with lower in-hospital mortality, shorter length of stay and readmission duration, and faster neutrophil and platelet engraftment; better scores on drug/alcohol use associates with faster platelet engraftment; better scores on family/support system availability and on relevant knowledge and receptiveness to education associates with decreased risk of mortality. The final rating score and medical outcomes are not significantly related; however, study findings underscore the prognostic value of the PACT subscales and the potential utility for screening of BMT candidates.
Introduction
Psychosocial risk factors have been reported to be associated with or predictive of treatment-related vulnerability [1] [2] [3] [4] and survival [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] in allogeneic BMT. Recent survey research shows that BMT clinicians consider psychosocial risk factors when making a decision whether or not to proceed with allogeneic BMT;
18 75% of the responding oncologists indicated that they have recommended not to proceed with BMT based on a psychosocial risk factor. Two psychosocial rating scales designed for use in solid organ transplant (SOT), the psychosocial assessment of candidates for transplantation (PACT) scale and the transplant evaluation rating scale (TERS), have been used [19] [20] [21] [22] and compared 23 in BMT. Researchers have found the PACT and TERS scales comparable in inter-rater reliability, with similar conceptual items correlating fairly highly with each other; however, the PACT scale offers more flexibility than the TERS in using clinical judgment. 23 Although the PACT was designed to study clinical decision making in psychosocial screening of SOT candidates, there is no research on the relationship of the PACT scores to medical outcomes post transplant, either in SOT or BMT. Authors of the PACT scale recommend that research should be conducted on 'how well do ratings on the PACT scale predict patient recovery, compliance, and physical health outcomes.' 19 Therefore, this research explores the clinical utility of the PACT scale for psychosocial screening in BMT. Specifically, medical outcomes post transplant are examined in relation to the PACT subscale scores and the final rating or the rater's overall impression of the candidate's quality for allogeneic BMT. Will patients with better PACT subscale scores and final rating score have better medical outcomes post transplant? Which of the PACT subscales will contribute most and least heavily to the final rating of allogeneic BMT candidates?
Materials and methods
As the utility of psychosocial assessment of BMT patients has been under debate, 8 the study is explorative and not hypothesis testing. From November 2003 to June 2007, the demographic and medical data were collected on 120 adult allogeneic patients at a major tertiary hospital in the US. All patients were treated on protocols that were reviewed and approved by the hospital's institutional review board (IRB), with informed consent obtained from all patients. These patients were seen pre-transplant for psychosocial assessment by an oncology social worker, selected from a pool of three oncology social workers assigned to the BMT program. The duration of the assessment process was 1.5 to 2 h, after which the social worker took approximately 5 min to complete a PACT scale for each patient. The PACT is a helpful and easy-to-use scale that any mental health professional (psychologist, psychiatrist or oncology social worker) completing the pre-transplant psychosocial assessment can use. Use of the PACT scale with allogeneic patients in the present exploratory study is part of a larger IRB-approved prospective study designed to verify the effect of lay care partners on medical outcomes; each patient consenting to this study has a PACT scale completed at baseline.
The PACT scale is a single page 10-item rating scale with high inter-rater reliability (intraclass correlation ¼ 0.85) in SOT. 19 Two of the 10 items, the initial and the final rating, are based on the clinician's judgment of candidate quality for transplant and graded from 0 ¼ poor to 4 ¼ excellent transplant candidate; the initial rating is just an impression that is formed before assessing each subscale and it was not used in this study. 
Statistical analysis
Categorical variables are summarized as frequency counts and percentages; continuous variables are summarized as the mean, s.d., median, minimum and maximum. Sixteen outcomes were assessed: three were binary (in-hospital mortality, 100-day mortality, any hospital readmission), five were continuous (length of stay, days until neutrophil engraftment, days until platelet engraftment, number of readmissions, and average number of readmission days), and eight were time-to-event (any acute graft-versus-host disease (GVHD), grades II-IV acute GVHD, grades III-IV acute GVHD, any chronic GVHD, extensive chronic GVHD, relapse, overall survival, and relapse-free survival). Analyses were performed to determine whether any of the eight PACT subscales or the final PACT rating was associated with these outcomes. Binary variables were analyzed using the Cochran-Armitage trend test to determine whether there is a trend in these outcomes as the PACT score increases (less psychosocial risk); results are summarized as frequency counts and percentages. Continuous variables were analyzed using the Jonckheere-Terpstra test to determine whether there is a trend in these outcomes as the PACT score increases: results are summarized as the median and range. Time-to-event outcomes were analyzed using the Cox proportional hazards analysis: results are summarized as the hazard ratio per one point increase in PACT score, the 95% confidence interval and the corresponding P-value.
Results
Patient characteristics are described in Table 1 . The median age of patients is 41; 87% are Caucasian and 52% are female. Patients are nearly equally divided by having a related or unrelated donor, and most patients have an acute leukemia diagnosis (51% have acute myeloid leukemia (AML) and 22% have acute lymphocytic leukemia (ALL)). The median length of inpatient hospital transplant stay is 30 days, and most patients survive the inpatient hospital transplant stay, with a 92% survival rate; 85% of patients survive 100 days post transplant. Most patients (85%) require an inpatient hospital readmission; 62% of patients have an episode of acute GVHD, 36% chronic GVHD, and a majority of patients (81%) remained relapse-free. The median follow-up of living patients is 14.6 months, with a range of 1.6 to 42.1 months.
Ratings for each PACT subscale and the final PACT rating are shown in Table 2 . As depicted, 70% to 89% of patients were rated with better scores (4 or 5) on all eight subscales. Noteworthy is the subscale Drug and Alcohol Use; 79% of patients were rated with a score of 5, indicating a large majority practice abstinence or rare substance use. In addition, compared with the other subscales, patients were more frequently rated with a score of 3 on Family and Support System Stability; Family and Support System Availability; Psychopathology, Stable Personality Factors; and Relevant Knowledge and Receptiveness to Education, indicating moderate concern about these aspects of psychosocial importance. Regarding the final rating scores of candidate quality for transplant, a majority (68%) were rated as good or excellent candidates.
Significant relationships between PACT ratings and binary or continuous outcomes are shown in Table 3 . The percentage of patients who die in the hospital decreases as compliance with medications/medical advice improves (P ¼ 0.047). In addition, better compliance is significantly associated with shorter length of stay (P ¼ 0.037), faster neutrophil engraftment (P ¼ 0.015), faster platelet engraftment (P ¼ 0.029) and shorter average readmission duration (P ¼ 0.038). Better or higher scores on the drug and alcohol use subscale, or less substance use, are associated with faster platelet engraftment (P ¼ 0.020). In addition, the percentage of patients who require readmission decreases as the risk for psychopathology lessens (P ¼ 0.044), as indicated by better or higher scores. Significant relationships between PACT ratings and time-to-event outcomes are shown in Table 4 . Decreased risk of mortality is significantly associated with better or higher scores on family or support system availability (P ¼ 0.042) and with better or higher scores on relevant knowledge and receptiveness to education (P ¼ 0.028). There is no significant relationship between the final PACT rating score and any post transplant outcomes (results not shown).
Regarding the contribution of each PACT subscale to the final rating, the first three subscales: Family or Support System Stability; Family Support System Availability; Psychopathology, Stable Personality Factors contributed most heavily to the social workers' final rating, these subscales contributed 52%, 53% and 42%, respectively. In contrast, Drug and Alcohol Use, Compliance with Medications and Medical Advice, and Healthy Lifestyle/ Ability to Sustain Change in Lifestyle comprise the bottom three subscales, contributing the least to the final rating of candidate quality for BMT, these subscales contributed 5%, 15% and 21%, respectively.
Discussion
Although the sample size of 120 patients may be perceived as a limitation of the study in that it precludes, for example, a detailed risk factor analysis by individual outcome, its findings add to the evolving discussion among BMT professionals regarding the utility of psychosocial eligibility criteria in allogeneic BMT. What is noteworthy is the conceptual similarity between select PACT subscales (Compliance with Medications/Medical Advice, Risk for Psychopathology, Drug/Alcohol Use, and Family/Support System Availability), which associate significantly with medical outcomes in this study, and six psychosocial risk factors in an earlier study (history of non-compliance, suicidal ideation, mild dementia, alcoholic, use of illicit drugs, and no lay care partner), which were identified by a majority of BMT professionals nationwide as contraindicated for allogeneic transplant. 18 Also noteworthy is the finding that a decreased risk of mortality is associated with better scores on the PACT subscale Family and Support System Availability, which corroborates the earlier research finding that in-hospital lay care partner support is prognostic of patient survival in allogeneic BMT.
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That earlier identified psychosocial risk factors in allogeneic BMT are conceptually similar to the PACT subscales, which in turn are significantly associated with medical outcomes such as engraftment, survival, length of stay and readmission, underscores the utility of the PACT subscales for screening a cluster of psychosocial issues that may combine as risk factors for treatment related vulnerability and medical outcomes in allogeneic BMT. The scientific reasons for some of the significant associations between psychosocial risk factors and medical outcomes are unclear, particularly the finding that noncompliance and drug and alcohol use associate with slower platelet engraftment. On the basis of clinical observation, patients who are non-compliant or have a history of addictions tend to not care for their bodies in a nurturing, disciplined manner and often do not engage well in self-care while going through BMT. These illness behaviors may bear witness to a mind-body connection that negatively affects engraftment, but this is conjectural and a topic for future research.
However, the study findings do raise the following question that begs attention here: What level of psychosocial risk warrants not proceeding with transplant? Illustrative is an actual case from the authors' clinical practice involving a 28-year-old male with transfusion-dependent aplastic anemia. This patient has a history of being noncompliant with medical appointments and medications, actively smokes marijuana and cigarettes, and has a weak caregiving plan. After deciding not to transplant, a recommendation was made for a substance abuse assessment. The patient tested positive for cocaine and treatment for poly-substance dependency was recommended by the chemical dependency counselor. The patient has not complied and continues with treatment in the cancer center for aplastic anemia with no plan to proceed with allogeneic BMT.
Such 'do not transplant' decisions are uneasy decisions, often contingent on the patient showing a 'take charge responsibility' for ameliorating their risk factor. 24 And, as study findings indicate, when making decisions about proceeding with BMT, more important than the PACT final rating (or the rater's overall impressions of the candidate's acceptability for transplant) are subscales representing aspects of psychosocial importance, such as family or support system stability, patient compliance, drug and alcohol use, and the potential effect of these on medical outcomes. The case illustration underscores the utility of the PACT subscales for screening a cluster of psychosocial issues that may combine as risk factors, reaching a threshold level beyond which allogeneic BMT cannot be justified on the basis of medical utility or possible medical benefit and outcome.
Thus, although the PACT scale seems helpful for pretransplant psychosocial screening, study findings suggesting its prognostic value with respect to medical benefit and outcomes in BMT are not without question when using the final rating score. As with any clinician, this may be because of the three social workers' freedom in the final rating to weigh the eight individual item ratings that are Unexpectedly, BMT social workers identified Compliance with Medications and Medical Advice as one of the two subscales contributing the least to their final rating. This contrasts with the compliance subscale accounting for 5 of the 10 significant relationships with medical outcomes. Compliance may not readily capture the social worker's attention, unless it is an obvious risk factor, whereas family/support system stability and availability typically capture the social worker's attention both as a potential strength or as a risk factor. The ability and commitment of patients to be compliant with the often complex and difficult medical regimes involved in allogeneic BMT warrants greater consideration before transplant.
The findings that the PACT subscales associating significantly with medical outcomes in this study are conceptually similar to psychosocial risk factors identified as contraindications for allogeneic BMT in an earlier nationwide study suggests a profile of high psychosocial risk. Future research will need to address such questions as follows: What level of psychosocial risk warrants not proceeding with transplant, and should this threshold level be based on statistical and/or practical significance? Is there a time when proceeding to transplant is justified even though harm based on aspects of psychosocial importance is foreseeable? Whatever be the decision, patients with irrefutable risk factors would benefit from targeted interventions before the transplant with the goal of decreasing the specific psychosocial risk and thus the negative effect on medical outcome. 
